Whipplewood Advisors LLC Takes $29,000 Position in Teladoc Health, Inc. (NYSE:TDOC)

Whipplewood Advisors LLC purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,200 shares of the health services provider’s stock, valued at approximately $29,000.

Several other hedge funds have also added to or reduced their stakes in TDOC. Versant Capital Management Inc lifted its position in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares during the period. Blue Trust Inc. raised its stake in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after buying an additional 1,854 shares during the last quarter. KBC Group NV lifted its holdings in Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after buying an additional 3,714 shares during the period. Westside Investment Management Inc. boosted its stake in Teladoc Health by 43.8% in the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock valued at $84,000 after acquiring an additional 2,800 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in Teladoc Health during the 3rd quarter worth $92,000. Institutional investors own 76.82% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on TDOC. Bank of America increased their price target on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Royal Bank of Canada raised their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. The Goldman Sachs Group increased their price target on shares of Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, February 18th. Finally, Piper Sandler decreased their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and an average price target of $11.44.

Insider Transactions at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.95% of the company’s stock.

Teladoc Health Stock Up 0.6 %

Shares of Teladoc Health stock opened at $9.56 on Friday. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $15.95. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The business’s 50 day simple moving average is $10.62 and its 200 day simple moving average is $9.57. The firm has a market cap of $1.65 billion, a PE ratio of -1.66 and a beta of 1.05.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.